V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160012194 | 160005824 | 1.57 | 84.6 | Palliative (P) | 2017-12-11 | 2018-01-12 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100568797 |
| 160012195 | 160005825 | 1.68 | 55 | Neo-adjuvant (N) | 2018-03-16 | 2018-03-22 | Paclitaxel 7 day | N | N | CARBOPLATIN | 100916685 |
| 160012196 | 160005826 | 1.73 | 64.5 | Palliative (P) | 2016-10-08 | 2016-10-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100757136 |
| 160012198 | 160005827 | 1.79 | 83.2 | null | 2018-09-30 | 2018-10-01 | NB HRNBL-1 COJEC Ind COURSE A | 02 | null | LIPOSOMAL DOXORUBICIN | 100102057 |
| 160012199 | 160005828 | null | 61.7 | Palliative (P) | 2016-09-03 | 2016-10-12 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101314332 |
| 160012201 | 160005829 | 1.73 | 77.5 | Palliative (P) | 2017-02-04 | 2017-02-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101509026 |
| 160012203 | 160005830 | 1.57 | 91.4 | Palliative (P) | 2017-01-29 | 2017-02-11 | null | 02 | N | ABEMACICLIB + FULVESTRANT | 100309288 |
| 160012205 | 160005831 | 1.63 | 64 | Palliative (P) | 2019-09-03 | 2019-09-04 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100703485 |
| 160012206 | 160005832 | 1.58 | 86.85 | Palliative (P) | 2016-07-31 | 2016-08-15 | NIVOLUMAB | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101177454 |
| 160012207 | 160005833 | 1.85 | 63 | Neo-adjuvant (N) | 2016-07-29 | 2016-07-29 | Temozolomide 200mg/m2 | N | N | DOXORUBICIN + OLARATUMAB | 101712479 |
| 160012208 | 160005834 | 1.64 | 49.4 | Palliative (P) | 2020-03-18 | 2020-03-18 | VIDE | 02 | N | TEMOZOLOMIDE | 101610548 |
| 160012209 | 160005835 | 0 | 57 | Palliative (P) | 2020-12-25 | 2021-01-19 | Cisplatin + Paclitaxel | 02 | N | IVA | 100853587 |
| 160012210 | 160005836 | 1.61 | 53.3 | Palliative (P) | 2019-08-28 | 2019-09-04 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100500598 |
| 160012211 | 160005837 | 1.75 | 54.7 | Palliative (P) | 2018-06-13 | 2018-07-18 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101005804 |
| 160012214 | 160005838 | null | null | Palliative (P) | 2018-01-28 | 2018-02-09 | DOXORUBICIN | 02 | null | DACARBAZINE + DOXORUBICIN | 101214477 |
| 160012216 | 160005839 | 1.89 | 84.3 | Curative (C) | 2020-10-23 | 2020-10-23 | NB HRNBL-1 COJEC Ind COURSE A | 02 | null | CYCLOPHOSPHAMIDE | 100419695 |
| 160012217 | 160005840 | 1.68 | 93.1 | 03 | 2016-12-11 | 2016-12-16 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100824395 |
| 160012222 | 160005841 | 1.73 | 85.6 | Palliative (P) | 2017-03-20 | 2017-03-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100976154 |
| 160012223 | 160005842 | 1.44 | 57.5 | Palliative (P) | 2018-11-13 | 2018-11-28 | Doxorubicin + Olaratumab | null | N | CISPLATIN + PEMETREXED | 101264442 |
| 160012224 | 160005843 | 1.73 | null | Palliative (P) | 2016-11-09 | 2016-11-24 | Ifosfamide | 02 | N | PACLITAXEL | 101456410 |
| 160012225 | 160005844 | 1.58 | 74.2 | 03 | 2016-07-27 | 2016-08-14 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101417475 |
| 160012232 | 160005845 | 1.48 | 77.6 | Curative (C) | 2019-03-26 | 2019-04-11 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100614076 |
| 160012233 | 160005846 | 1.75 | 77.55 | null | 2020-03-22 | 2020-04-14 | Carboplatin + Etoposide iv&po | null | null | TRIAL | 101575449 |
| 160012234 | 160005847 | 1.69 | 78.9 | Palliative (P) | null | 2016-07-24 | Trial Unspecified | N | N | ENZALUTAMIDE | 100784164 |
| 160012240 | 160005850 | null | null | Palliative (P) | 2017-12-11 | 2017-12-31 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | TRIAL UNSPECIFIED | 100329664 |
| 160012243 | 160005852 | 1.74 | 74 | Palliative (P) | 2017-09-04 | 2017-09-05 | Trial Unspecified | 02 | null | ATOMIC-MESO TRIAL | 101765296 |
| 160012244 | 160005853 | 1.62 | 76.7 | Palliative (P) | null | null | PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100667949 |
| 160012245 | 160005854 | 1.75 | 76 | null | 2019-12-09 | 2019-12-23 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100014571 |
| 160012246 | 160005855 | 1.69 | 88.6 | Palliative (P) | 2018-05-18 | 2018-06-03 | EW EuroEwing 2012 Arm B VDC | N | null | DOXORUBICIN | 100560806 |
| 160012248 | 160005856 | 1.5 | 82 | Adjuvant (A) | null | 2020-01-16 | Doxorubicin + Ifosfamide | 01 | N | LIPOSOMAL DOXORUBICIN | 100449824 |
| 160012251 | 160005857 | 1.69 | 69 | Curative (C) | 2017-03-06 | 2017-03-28 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100720359 |
| 160012252 | 160005858 | 1.74 | 69.5 | Palliative (P) | 2017-06-14 | 2017-06-17 | Cisplatin + Pemetrexed | 02 | N | EURO-EWING | 100156918 |
| 160012256 | 160005859 | 1.81 | 70.2 | Palliative (P) | 2018-07-13 | 2018-07-13 | Enzalutamide | 02 | N | PACLITAXEL | 101398612 |
| 160012257 | 160005860 | 1.61 | 100 | Palliative (P) | 2018-08-31 | 2018-09-20 | IVA | 01 | N | DOXORUBICIN + OLARATUMAB | 100425878 |
| 160012258 | 160005861 | 1.77 | 123.8 | Neo-adjuvant (N) | 2016-12-17 | 2016-12-25 | NB HRNBL-1 COJEC Ind COURSE A | null | N | DOXORUBICIN + OLARATUMAB | 100230691 |
| 160012260 | 160005862 | 1.6 | 80 | null | 2020-09-04 | 2020-09-21 | Trial Unspecified | 02 | N | LIPOSOMAL DOXORUBICIN | 100346698 |
| 160012263 | 160005863 | 1.59 | 51 | Palliative (P) | 2019-05-22 | 2019-05-22 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100861095 |
| 160012264 | 160005864 | 1.85 | 133.4 | Curative (C) | 2019-06-10 | 2019-06-25 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100607029 |
| 160012265 | 160005865 | 1.74 | 90.4 | Palliative (P) | 2018-06-28 | 2018-07-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100614509 |
| 160012266 | 160005866 | 1.78 | 89.6 | Palliative (P) | 2019-07-24 | 2019-07-24 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100879713 |
| 160012270 | 160005867 | 1.74 | 70.8 | Palliative (P) | 2017-03-21 | 2017-03-28 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101046547 |
| 160012271 | 160005868 | 1.77 | 88 | null | 2020-02-08 | 2020-02-08 | Carboplatin + Paclitaxel (3 weekly) | 02 | Y | ABIRATERONE | 100815097 |
| 160012272 | 160005869 | 1.63 | 54.6 | Curative (C) | 2019-08-12 | 2019-08-21 | Liposomal Doxorubicin (Caelyx) | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101145234 |
| 160012273 | 160005870 | 1.55 | 70.8 | Palliative (P) | 2019-05-25 | 2019-05-31 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101600461 |
| 160012274 | 160005871 | 1.61 | 93.2 | Palliative (P) | null | 2019-04-12 | Cisplatin + Doxorubicin | 02 | null | TRIAL UNSPECIFIED | 100819619 |
| 160012275 | 160005872 | 1.55 | null | Palliative (P) | 2017-04-22 | 2017-05-04 | Bevacizumab 15mg/kg | 02 | N | DOXORUBICIN | 100178361 |
| 160012277 | 160005873 | 1.78 | 62.9 | Palliative (P) | 2018-03-03 | 2018-03-11 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 101816373 |
| 160012278 | 160005874 | 1.66 | 82.6 | Palliative (P) | null | 2018-02-01 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101740566 |
| 160012279 | 160005875 | 1.78 | 80.6 | Palliative (P) | 2019-01-20 | 2019-01-20 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100710441 |
| 160012280 | 160005876 | 1.8 | 72 | Palliative (P) | 2016-10-15 | 2016-10-15 | Doxorubicin + Ifosfamide | 02 | N | IFOSFAMIDE | 101697666 |